Wei Wei

Dr. Wei Wei

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2020 in The Journal of Clinical Psychiatry
Verified
Journal Article
Closed access
PDF file
YZYamin Zhang
Yamin Zhang
QWQiang Wang
Qiang Wang
GRGavin P. Reynolds
Gavin P. Reynolds
WYWeihua Yue
Weihua Yue
WDWei Deng
Wei Deng
FCfor the Chinese Antipsychotics Pharmacogenomics Consortium
for the Chinese Antipsychotics Pharmacogenomics Consortium
How soon is too soon to look for metabolic syndrome in your patients with schizophrenia? This randomized open-label trial investigates 7 risk factors of 5 atypical and 2 typical antipsychotics to make recommendations for monitoring metabolic measurements.

2 April 2020 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
WWWei Wei
Wei Wei
YZYamin Zhang
Yamin Zhang
YLYinfei Li
Yinfei Li
YMYajin Meng
Yajin Meng
MLMingli Li
Mingli Li
TLTao Li
Tao Li
Myelination is key to effective message passing in the central nervous system and is likely linked to the pathogenesis of schizophrenia (SZ). Emerging evidence indicates that a large portion of intracortical myelin insulates inhibitory interneurons that are highly relevant to pathogenesis of schizophrenia. Here for the first time, we characterized intracortical myelination across the entire cortical surface in first‐episode treatment‐naïve patients with schizophrenia (FES) using T1w/T2w ratio of structural MRI, FES patients exhibited significantly higher myelin content in the left inferior parietal lobe, supramarginal gyrus, and superior temporal gyrus in the superficial layer, as well as left IPL in the middle layer, but significantly lower myelin content in the left middle insula and posterior cingulate gyrus. Years of education, a proxy for onset of functional decline, significantly altered the relationship between abnormal parietal and posterior cingulate myelination and clinical symptoms, indicating that the pathoplastic role of myelination hinges on the age of onset of functional decline. In addition, higher myelination generally related to better cognitive function in younger subjects but worse cognitive function in older subjects. We conclude that FES is characterized by increased myelination of the superficial layers of the parietal–temporal association cortex, but reduced myelination of the cingulo‐insular midcortical layer cortex. Intracortical myelin content affects both cognitive functioning and symptom burden in FES, with the effect conditional upon age and timing of onset of functional decline. These results suggest myelination might be a critical biological target for procognitive interventions in SZ.

13 July 2023 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
WWWei Wei
Wei Wei
LDLihong Deng
Lihong Deng
CQChunxia Qiao
Chunxia Qiao
YYYubing Yin
Yubing Yin
YZYamin Zhang
Yamin Zhang
TLTao Li
Tao Li

1 July 2019 in Schizophrenia Research
Verified
Journal Article
Closed access
CWChengyu Wang
Chengyu Wang
QWQiang Wang
Qiang Wang
XLXiaojing Li
Xiaojing Li
YZYamin Zhang
Yamin Zhang
WWWei Wei
Wei Wei
TLTao Li
Tao Li

28 September 2021 in Cerebral Cortex
Verified
Journal Article
Closed access
PDF file
WWWei Wei
Wei Wei
YYYubing Yin
Yubing Yin
YZYamin Zhang
Yamin Zhang
XLXiaojing Li
Xiaojing Li
MLMingli Li
Mingli Li
TLTao Li
Tao Li
Aberrations in intracortical myelination are increasingly being considered as a cardinal feature in the pathophysiology of schizophrenia. We investigated the network-level distribution of intracortical myelination across various cortex depths. We enrolled 126 healthy subjects and 106 first-episode drug-naïve schizophrenia patients. We used T1w/T2w ratio as a proxy of intracortical myelination, parcellated cortex into several equivolumetric surfaces based on cortical depths and mapped T1w/T2w ratios to each surface. Non-negative matrix factorization was used to generate depth-dependent structural covariance networks (dSCNs) of intracortical myelination from 2 healthy controls datasets—one from our study and another from 100-unrelated dataset of the Human Connectome Project. For patient versus control comparisons, partial least squares approach was used; we also related myelination to clinical features of schizophrenia. We found that dSCNs were highly reproducible in 2 independent samples. Network-level myelination was reduced in prefrontal and cingulate cortex and increased in perisylvian cortex in schizophrenia. The abnormal network-level myelination had a canonical correlation with symptom burden in schizophrenia. Moreover, myelination of prefrontal cortex correlated with duration of untreated psychosis. In conclusion, we offer a feasible and sensitive framework to study depth-dependent myelination and its relationship with clinical features.

7 November 2023 in Schizophrenia
Verified
Journal Article
Open access
PDF file
HYHua Yu
Hua Yu
PNPeiyan Ni
Peiyan Ni
YTYang Tian
Yang Tian
LZLiansheng Zhao
Liansheng Zhao
MLMingli Li
Mingli Li
TLTao Li
Tao Li
Schizophrenia has been linked to polymorphism in genes encoding components of the complement system, and hyperactive complement activity has been linked to immune dysfunction in schizophrenia patients. Whether and how specific complement components influence brain structure and cognition in the disease is unclear. Here we compared 52 drug-naïve patients with first-episode schizophrenia and 52 healthy controls in terms of levels of peripheral complement factors, cortical thickness (CT), logical memory and psychotic symptoms. We also explored the relationship between complement factors with CT, cognition and psychotic symptoms. Patients showed significantly higher levels of C1q, C4, factor B, factor H, and properdin in plasma. Among patients, higher levels of C3 in plasma were associated with worse memory recall, while higher levels of C4, factor B and factor H were associated with thinner sensory cortex. These findings link dysregulation of specific complement components to abnormal brain structure and cognition in schizophrenia.